ContextThe Women's Health Initiative (WHI) trial of estrogen plus progestin was stopped
early because of adverse effects, including an increased risk of stroke in the estrogen plus …

This book, through its several editions, has continued to adapt to evolving areas of research
in epidemiology and statistics, while maintaining the original objective of being non-…

Background Subclinical depression, often clinically unrecognized, may pose increased risk
of cardiovascular disease. Few studies have prospectively investigated cardiovascular …

Objective: To determine the relationship between increasing depressive symptoms and
cardiovascular events or mortality. Design: Cohort analytic study of data from randomized …

ContextPostmenopausal women have a greater risk than men of developing Alzheimer
disease, but studies of the effects of estrogen therapy on Alzheimer disease have been …

Little is known about the patterns of treatment and adequacy of blood pressure control in
older women. The Women’s Health Initiative, a 40-center national study of risk factors and …

The aim of this updated statement is to provide comprehensive and timely evidence-based
recommendations on the prevention of ischemic stroke among survivors of ischemic stroke or …

Importance Menopausal hormone therapy continues in clinical use but questions remain
regarding its risks and benefits for chronic disease prevention. Objective To report a …

ContextMultiple epidemiologic studies and some trials have linked diet with cardiovascular
disease (CVD) prevention, but long-term intervention data are needed.ObjectiveTo test the …

Stroke has multiple etiologies, but the underlying genes and pathways are largely unknown.
We conducted a multiancestry genome-wide-association meta-analysis in 521,612 …